Kraematon Investment Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $341K | Buy |
1,839
+3
| +0.2% | +$557 | 0.32% | 69 |
|
|
2025
Q1 | $385K | Buy |
1,836
+2
| +0.1% | +$419 | 0.39% | 62 |
|
|
2024
Q4 | $326K | Buy |
1,834
+3
| +0.2% | +$533 | 0.32% | 65 |
|
|
2024
Q3 | $362K | Buy |
1,831
+3
| +0.2% | +$592 | 0.35% | 62 |
|
|
2024
Q2 | $314K | Buy |
1,828
+3
| +0.2% | +$515 | 0.32% | 66 |
|
|
2024
Q1 | $332K | Sell |
1,825
-32
| -2% | -$5.83K | 0.33% | 66 |
|
|
2023
Q4 | $288K | Buy |
1,857
+3
| +0.2% | +$465 | 0.32% | 69 |
|
|
2023
Q3 | $276K | Buy |
1,854
+3
| +0.2% | +$447 | 0.34% | 65 |
|
|
2023
Q2 | $249K | Buy |
1,851
+4
| +0.2% | +$539 | 0.27% | 72 |
|
|
2023
Q1 | $294K | Buy |
1,847
+3
| +0.2% | +$478 | 0.34% | 65 |
|
|
2022
Q4 | $298K | Sell |
1,844
-122
| -6% | -$19.7K | 0.32% | 67 |
|
|
2022
Q3 | $264K | Sell |
1,966
-27
| -1% | -$3.63K | 0.34% | 70 |
|
|
2022
Q2 | $305K | Buy |
1,993
+56
| +3% | +$8.57K | 0.35% | 63 |
|
|
2022
Q1 | $314K | Buy |
1,937
+3
| +0.2% | +$486 | 0.3% | 70 |
|
|
2021
Q4 | $262K | Buy |
+1,934
| New | +$262K | 0.23% | 81 |
|